Cargando…
Personalized ß-lactam dosing in patients with coronavirus disease 2019 (COVID-19) and pneumonia: A retrospective analysis on pharmacokinetics and pharmacokinetic target attainment
Pathophysiological changes are important risk factors for critically ill patients with pneumonia manifesting sub-therapeutic antibiotic exposures during empirical treatment. The effect of coronavirus disease 2019 (COVID-19) on antibiotic dosing requirements is uncertain. We aimed to determine the ef...
Autores principales: | Chiriac, Ute, Frey, Otto R., Roehr, Anka C., Koeberer, Andreas, Gronau, Patrick, Fuchs, Thomas, Roberts, Jason A., Brinkmann, Alexander |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183774/ https://www.ncbi.nlm.nih.gov/pubmed/34087915 http://dx.doi.org/10.1097/MD.0000000000026253 |
Ejemplares similares
-
The role of a chest computed tomography severity score in coronavirus disease 2019 pneumonia
por: Salaffi, Fausto, et al.
Publicado: (2020) -
Risk factors for Coronavirus disease 2019 pneumonia after admission outside Wuhan, China
por: Jie, Li Shao, et al.
Publicado: (2020) -
A case report of a pregnant woman infected with coronavirus disease 2019 pneumonia
por: Peng, Jing, et al.
Publicado: (2020) -
Coronavirus disease 2019 (COVID-19) pneumonia in a hemodialysis patient: A case report
por: Huang, Luyan, et al.
Publicado: (2020) -
Inflammatory cytokine depletion in severe coronavirus disease 2019 infectious pneumonia: A case report
por: Yang, Bo, et al.
Publicado: (2020)